by Xcellerant Ventures | Jul 25, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-DNA-Case-Study-Layout.pdf Key Takeaways: The CRISPR Analytics Platform is an in vitro tool for measuring CRISPR editing efficiency, as well as, RNP...
by Xcellerant Ventures | Jul 9, 2024 | Portfolio Company News
Origionally posted on EIN Presswire: https://www.einpresswire.com/article/710284206/lenoss-medical-oversubscribes-4-million-series-a-financing Dom Messerli isn’t an M.D., but based on his success in the medical device field so far, he knows how to fix a spine. He’s a...
by Xcellerant Ventures | Jul 9, 2024 | Portfolio Company News
Origionally posted on AdviNOW Medical’s website: https://advinow.com/advinow-featured-in-gartner-hype-cycle-for-digital-clinical-encounters-for-fourth-consecutive-year/ We are thrilled to announce that AdviNOW has been recognized in the Gartner Hype...
by Xcellerant Ventures | Jun 11, 2024 | Portfolio Company News
Origionally posted on Empowered Patient Podcast: https://empoweredpatientradio.com/unlocking-the-power-of-crispr-technology-for-drug-development-with-ross-bundy-crispr-qc Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR...
by Xcellerant Ventures | Jun 6, 2024 | Portfolio Company News
Origionally posted on Anuncia Medical’s website: https://anunciamedical.com/anuncia-medical-announces-first-successful-us-implant-of-the-companys-reflow-device-with-sonolucent-cranial-plate-to-noninvasively-visualize-flushing-of-hydrocephalus-shunts/ ...
